Atann is a Pharmaceutical group based in Portugal that is to manufacture & supply Cannabis and Cannabis derived Active Pharmaceutical Ingredients (APIs), domestically and internationally. Atann’s API portfolio comprises a range of high-quality Cannabinoid API extracts and isolates, produced using innovative and sustainable extraction and purification methods.

Atann provides a range of contract development and manufacturing services. We are a ‘one stop shop’ for our clients to supply Good Manufacturing Practices (GMP) certified dry Cannabis flower to EU markets. We provide a regulated Pharma pathway to transform Good Agricultural and Collection Practices (GACP) compliant Cannabis into GMP certified Cannabis medicines. We support our clients’ product commercialisation, through provision of International Council for Harmonisation (ICH) compliant stability studies, analytical method development and validation, and regulatory filing support.